Treatment for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults. Starts Mar 15, due to complete Dec 15 [6].
24/02/2015 17:53:02
Jun 14: GW Pharmaceuticals announce physician reports of efficacy and safety data on 27 children and young adults with treatment-resistant epilepsy who have been treated with cannabidiol, Epidiolex, for a period of 12 weeks. Uncontrolled data from two hospital sites in the US that were generated under expanded access Investigational New Drug applications (INDs) authorised by the FDA were made available to the Company. A high proportion show a reduction in seizure frequency of greater than 50% and a portion of patients were reported to be seizure-free at the end of 12 weeks of treatment [1].
18/06/2014 12:55:29
References
Available only to registered users
|
